iShares Nasdaq Biotechnology (IBB) Sees Green-to-Red Reversal
- Top 10 News for 9/19 - 9/23: Twitter on the Auction Block; Allergan Bolsters NASH Effort; Microsoft Returns Value
- Wall Street falls as energy lags; shares post gains on week
- Rumored Forever, Twitter (TWTR) May Have Finally Put the 'For Sale' Sign Up
- Facebook (FB) Shares Under Pressure on Reports Video Ad Metrics Were Artificially Inflated
- Brookfield Infrastructure (BIP)-Led Consortium to Take Controlling Stake in Petrobras' (PBR) NTS for $5.2B
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
iShares Nasdaq Biotechnology (NASDAQ: IBB) is coming in sharply from earlier highs and have turned red. IBB is down 0.3% currently.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Fed Proposes Aggressive Rule on Wall Street Commodity Holdings
- BlackBerry (BBRY) calls active on 5 calls for every 1 put into Q2
- Apple (AAPL) option volume builds as shares trade near low of day
Create E-mail Alert Related CategoriesETFs, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!